Altium Capital Management’s Cerenome CNSY Stock Holding History

Altium Capital Management’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,757	Closed	-$628K	–	19
2025 Q3	$628K	Buy	+36,757	New	+$451K	100%	1

Other funds holding CNSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Altium Capital Management's CNSY Position: Q4 2025 in Review

Altium Capital Management sold out of Cerenome (CNSY) in Q4 2025, closing a stake of 36,757 shares — an estimated $628K sold.

Altium Capital Management first reported a position in CNSY in Q3 2025 and held it in 1 quarter. The position peaked at $628K in Q3 2025. 25 funds tracked by Wall St. Rank hold CNSY as of Q4 2025.

Altium Capital Management reported no remaining Cerenome position as of Q4 2025 after selling out during the quarter.
Altium Capital Management sold 36,757 Cerenome shares in Q4 2025, an estimated $628K.
Altium Capital Management first reported a position in Cerenome in Q3 2025 and held it in 1 quarter.
Altium Capital Management's Cerenome position peaked at $628K in Q3 2025.
25 funds tracked by Wall St. Rank held Cerenome as of Q4 2025.

Based on Altium Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.